Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine pretreatment to reduce propofol injection pain
ChiCTR2100052742Phase 4Recruiting
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in propofol injection site pain (PISP) (3 arms), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoint: Incidence of pain on propofol injection. Started Nov 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
propofol injection site pain (PISP)
Beyond the preview
Go deeper on ChiCTR2100052742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052742.